147 related articles for article (PubMed ID: 16336424)
1. Cypher versus taxus: are there differences?
Silber S
J Interv Cardiol; 2005 Dec; 18(6):441-6. PubMed ID: 16336424
[TBL] [Abstract][Full Text] [Related]
2. Which parameter should be chosen as primary endpoint for randomized drug-eluting stent studies?
Silber S
J Interv Cardiol; 2004 Dec; 17(6):375-85. PubMed ID: 15546289
[TBL] [Abstract][Full Text] [Related]
3. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
Silber S; Herdeg C
Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
[TBL] [Abstract][Full Text] [Related]
4. [When are drug-eluting stents effective? A critical analysis of the presently available data].
Silber S
Z Kardiol; 2004 Sep; 93(9):649-63. PubMed ID: 15365732
[TBL] [Abstract][Full Text] [Related]
5. Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries.
Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Liu HB; Xu B; Wu YJ; Yuan JQ; Chen J; Dai J; You SJ; Ma WH
Chin Med J (Engl); 2006 Jan; 119(1):21-5. PubMed ID: 16454977
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
7. Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials.
Biondi-Zoccai GG; Agostoni P; Abbate A; Testa L; Burzotta F; Lotrionte M; Crea F; Biasucci LM; Vetrovec GW; Colombo A
Int J Cardiol; 2005 Apr; 100(1):119-23. PubMed ID: 15820294
[TBL] [Abstract][Full Text] [Related]
8. ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?
Buellesfeld L; Grube E
Herz; 2004 Mar; 29(2):167-70. PubMed ID: 15054589
[TBL] [Abstract][Full Text] [Related]
9. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.
Iijima R; Mehilli J; Schömig A; Kastrati A
Minerva Cardioangiol; 2006 Oct; 54(5):539-55. PubMed ID: 17019392
[TBL] [Abstract][Full Text] [Related]
10. The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) trial study design: advancing the active-control evaluation of second-generation drug-eluting stents.
Wang TY; Hasselblad V; Peterson JL; Wijns W; Parhizgar A; Kereiakes DJ; Krucoff MW
Am Heart J; 2007 May; 153(5):743-8. PubMed ID: 17452147
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation.
Camenzind E; Wijns W; Mauri L; Boersma E; Parikh K; Kurowski V; Gao R; Bode C; Greenwood JP; Gershlick A; O'Neill W; Serruys PW; Jorissen B; Steg PG;
Am Heart J; 2009 Dec; 158(6):902-909.e5. PubMed ID: 19958855
[TBL] [Abstract][Full Text] [Related]
12. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
13. Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II.
Silber S; Hamburger J; Grube E; Pfisterer M; Belardi J; Webb J; Zmudka K; Nienaber C; Hauptman K; Rutsch W; Dawkins K; Drzewiecki J; Koglin J; Colombo A
Herz; 2004 Mar; 29(2):171-80. PubMed ID: 15057438
[TBL] [Abstract][Full Text] [Related]
14. [Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis].
Chen JL; Yang YJ; Qiao SB; Yao M; Qin XW; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):305-7. PubMed ID: 17711652
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous coronary intervention with everolimus-eluting stents (Xience V): systematic review and direct-indirect comparison meta-analyses with paclitaxel-eluting stents (Taxus) and sirolimus-eluting stents (Cypher).
Biondi-Zoccai G; Lotrionte M; Moretti C; Agostoni P; Sillano D; Laudito A; Sheiban I
Minerva Cardioangiol; 2008 Feb; 56(1):55-65. PubMed ID: 18432169
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients.
Romagnoli E; Leone AM; Burzotta F; Trani C; Angeloni G; Materazzo G; Niccoli G; De Vita M; Perfetti M; Mazzari MA; Mongiardo R; Rebuzzi AG; Schiavoni G; Crea F
J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):589-94. PubMed ID: 18475127
[TBL] [Abstract][Full Text] [Related]
17. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
[TBL] [Abstract][Full Text] [Related]
18. Polymer-based paclitaxel-eluting coronary stents. Clinical results in de novo lesions.
Chieffo A; Colombo A
Herz; 2004 Mar; 29(2):147-51. PubMed ID: 15054587
[TBL] [Abstract][Full Text] [Related]
19. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels.
Quizhpe AR; Feres F; de Ribamar Costa J; Abizaid A; Maldonado G; Costa R; Abizaid A; Cano M; Moreira AC; Staico R; Mattos LA; Tanajura LF; Chaves A; Centemero M; Sousa AM; Sousa JE
Am Heart J; 2007 Aug; 154(2):373-8. PubMed ID: 17643591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
